Targeted Polymer-Peptide Conjugates for E-Selectin Blockade in Renal Injury

Area of Science:

• Nephrology
• Immunology
• Polymer Chemistry

Background:

• Leukocyte infiltration drives kidney injury in acute kidney injury (AKI) and chronic kidney disease (CKD).
• Cell adhesion molecules (CAMs) like E-selectin mediate leukocyte migration.
• Previous small-molecule inhibitors targeting CAMs have failed in clinical trials.

Purpose of the Study:

• To investigate a synthetic polymer, P-Esbp, designed to block E-selectin-mediated leukocyte infiltration.
• To evaluate the efficacy of P-Esbp in reducing kidney inflammation in AKI and CKD models.

Main Methods:

• Synthesized P-Esbp by conjugating an E-selectin binding peptide (Esbp) to an HPMA copolymer.
• Tested P-Esbp in a mouse model of renal ischemia-reperfusion injury (RIRI) for AKI.
• Assessed P-Esbp in an adenine-induced kidney injury model for CKD.

Main Results:

• P-Esbp showed prolonged circulation and accumulated in kidneys.
• P-Esbp treatment suppressed E-selectin and reduced inflammation in the AKI model.
• P-Esbp had limited effect in the CKD model due to compensatory roles of P-selectin and VCAM-1.

Conclusions:

• E-selectin blockade is effective in AKI but not CKD, highlighting compensatory CAM mechanisms.
• Combined blockade of multiple CAMs may be necessary for effective treatment of renal injury.